We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Arterial Disease Risk Score Predicts Cardiovascular Events

By HospiMedica International staff writers
Posted on 04 Jun 2013
A new study describes a prediction model to aid doctors in more accurately determining the risk cardiovascular disease (CVD) patients face for developing a new event.

Researchers at University Medical Center (UMC; Utrecht, The Netherlands), Erasmus Medical Center (Rotterdam, The Netherlandsl), and other institutions, conducted a study involving 5,788 patients referred with various clinical manifestations of arterial disease between January 1996 and February 2010. More...
The data were used for the development and validation of stratification and prediction models of recurrent event risk based on vascular risk factors, imaging, or both. In all, 788 recurrent vascular events—such as myocardial infarction (MI), stroke, or vascular death—were observed during a mean 4.7 years of follow-up.

The end result was a Secondary Manifestations of ARTerial disease (SMART) model for prediction of 10-year recurrent vascular event risk, based on age and sex, in addition to clinical parameters that included medical history, current smoking, systolic blood pressure, and laboratory biomarkers. By using the clinical parameters alone model—without imaging or ultrasound data—there was less than 20% risk in 59% of patients, 20%–30% risk in 19%, and over 30% risk in 23%. The study was published online first on April 10, 2013, in Heart.


“Up to now, we put all patients with vascular disease in one and the same high-risk group, even if we knew from daily practice that there is an enormous variation in the risk between patients,” said study coauthor Prof. Frank Visseren, MD, a UMC specialist in internal and vascular medicine. “Some patients have a high risk while many others have only a low or normal risk of a recurring cardiovascular event; but until recently we were not able to differentiate between them. By using the SMART risk score that is now possible, which means that we can give better treatment advice to patients.”

Related Links:

University Medical Center
Erasmus Medical Center




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Radiofrequency Generator
GX1
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new Cora Torqueable Microcatheters expand our coronary portfolio supporting patients with coronary artery disease (photo courtesy of Reflow Medical)

Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions

Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.